Publications
Detailed Information
Identification of a patient group at low risk for parametrial invasion in early-stage cervical cancer
Cited 21 time in
Web of Science
Cited 25 time in Scopus
- Authors
- Issue Date
- 2010-12
- Publisher
- ACADEMIC PRESS INC ELSEVIER SCIENCE
- Citation
- GYNECOLOGIC ONCOLOGY; Vol.119 3; 426-430
- Keywords
- Cervical cancer ; Surgery ; Prognostic factor ; Parametrial invasion ; Parametrium ; Magnetic resonance imaging
- Abstract
- Aim. Using parameters obtained from magnetic resonance imaging (MRI), we constructed a prediction model for parametrial invasion (PMI) of cervical cancer and validated the model in different sets of patients. Patients and methods. Retrospectively, 251 patients with cervical cancer stages IA2-IIA, who had received a radical hysterectomy, were assigned to training and validation cohorts. After the development of the scoring index using logistic coefficient analysis, the performance of the prediction model was assessed using independent validation sets. Results. In the training cohort (n=167), multivariate analysis indicated that the patient`s stage, the cephalocaudal tumor diameter measured by MRI, and finding of PMI as obtained by MRI were independent predictors of PMI (P=0.010, <0.001, and 0.020, respectively). These predictors were internally validated by a rigorous bootstrapping method with statistical significance. The scoring index was created based on logistic coefficients, and the maximal score yielding a negative likelihood ratio less than 0.05 was selected as a cutoff. The cutoff was translated into the following criteria identifying a very low-risk group for PMI: (1) FIGO stage IA2-IBI, (2) no MRI finding suggesting PM!, and (3) cephalocaudal tumor diameter less than 1.0 cm by MRI. The negative predictive value (NPV) was 98.5% (95% confidence interval [CI]=91.7% to 100%). In the external validation cohort (n=84), the NPV was 100% (95% CI=90% to 100%). Conclusion. The current prediction model showed reliable performance for the identification of patients at low risk for PMI. It may be useful for stratification of patients and evaluation of results in future trials. (C) 2010 Elsevier Inc. All rights reserved.
- ISSN
- 0090-8258
- Language
- English
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.